Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.58 |
| ▸ | TOP1 | P11387 | 3/20 | 0.51 |
| ▸ | CYCS | P99999 | 4/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.43 |
| ▸ | AGER | Q15109 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22461492 | 1.00 | TERT (0.58) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL22461491 | 1.00 | TERT (0.58) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL8994447 | 0.85 | TOP1 (0.60) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL9910535 | 0.81 | ABCG2 (0.55) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL14077524 | 0.79 | ABCG2 (0.54) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL7241022 | 0.79 | TOP1 (0.58) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL1974241 | 0.79 | TOP1 (0.68) | TERTTOP1CYCSABCG2MEN1 | |
| SCHEMBL15580416 | 0.79 | TERT (0.65) | TERTTOP1CYCSABCG2KMT2A | |
| Tmpyp4 SCHEMBL265519 | 0.77 | TERT (0.97) | TERTTOP1CYCSABCG2ENPP2 | |
| Tmpyp4 SCHEMBL29369473 | 0.76 | TERT (1.00) | TERTTOP1CYCSABCG2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200298194-A1 | ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200298194-A1 | ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES | ANXA6, ANXA1, ANXA11 | TERT 888/4885TOP1 917/4885CYCS 2268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.